Advertisement
U.S. markets closed

Regencell Bioscience Holdings Limited (RGC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
4.5000+1.1000 (+32.35%)
At close: 04:00PM EDT
4.3000 -0.20 (-4.44%)
After hours: 07:57PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close3.4000
Open3.6200
Bid3.8000 x 400
Ask8.0000 x 1800
Day's Range3.1670 - 4.9954
52 Week Range3.1600 - 31.3000
Volume55,898
Avg. Volume2,842
Market Cap58.558M
Beta (5Y Monthly)-0.24
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for RGC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Regencell Bioscience Holdings L
    CNK: What does Argus have to say about CNK?CINEMARK HOLDINGS INC has an Investment Rating of SELL; a target price of $14.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more